Good Quality for 99% Purity Lab Offer Delta Sleep-Inducing Peptide (DSIP)(62568-57-4) CAS NO.62568-57-4

This is Allen  from Zhengzhou Filter Biotechnology Co.,Ltd.We are the professional supplier of peptide products in China over 10 years. we have Professional Lab to confirm the Quality and Serive for all clients in long-term run cooperation.
Our Company as a Pharmaceutical Raw Material Manufacturer specialize in R&D the New Drugs and Producing the Generic Medicine:

Amino Acids&Vitamins
Pharmaceutical Polypeptide,
Comestic Polypeptide,
Veterinary Peptide and 
Pharmaceutical APIs.
Due to of the high quality and good service, They have been exported more than 30 countries. 
Sincerely hope to have a chance to cooperate with you

Description
 
Delta sleep-inducing peptide, abbreviated DSIP, is a neuropeptide that when infused into the mesodiencephalic ventricle of recipient rabbits induces spindle and delta EEG activity and reduced motor activities.[1]

Its aminoacid sequence is TRP-ALA-GLY-GLY-ASP-ALA-SER-GLY-GLU However, the gene is unknown[citation needed], raising serious questions regarding the actual existence of this peptide in Name:Dsip
Other Name: Delta Sleep Inducing Peptide 
CAS: 62568-57-4 
Sequence: TRP-ALA-GLY-GLY-ASP-ALA-SER-GLY-GLU 
MF: C35H48N10O15 
MW: 848.813620 
Purity: 99% 
Appearance: White Lyophilized Powder 
Place of Origin: China 
Standard: USP 
Certification: SGS 
Method of Analysis: HPLC 
Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C. 
 
Usage: 
DSIP (Delta Sleep-inducing Peptide) is a neuropeptide found in the hypothalamus, pituitary, and adrenal glands. 
Its isolation has allowed for extensive research which has found several possible primary and peripheral roles of this peptide. 
First, DSIP has been shown to induce sleep. Second, it may have benefits as an analgesic in treatment of chronic pain, 
sometimes as an adjunct treatment. Third, DSIP has been shown to block ACTH release and decrease levels of ACTH, stimulate LH release, and act as an inhibitor of the secretion of somatostatin. 
The source of production of DSIP is yet unknown; It may be produced in the central nervous system or in a peripheral organ. It is thought to pass. Through the blood-brain barrier (BBB) more easily than most known neuropeptides. 
As mentioned, DSIP has shown positive results in inducing slow-wave EEG (sleep). 
It has been shown to help treat narcolepsy and restore disturbed sleep patterns to normal sleep rhythms.